Figure 1: The PXRD pattern of Ceo2 Nanoparticles
Samples | Cellparameters (Å) | d space (Å) | Volume (Å)3 | Crystalline size (nm) | Structure | ||
C1 | 5.4 | 1.759 | 158 | 49.1 | FCC | ||
samples | JCPDS CardNo. |
D-Spacing (Å) | Cell Parameters (Å) | Cell Volume (Å)3 | |||
Ca lculations | JCPDS | Ca lculations | JCPDS | Calculations | JCPDS | ||
CeO2 | 81-0792 | 1.7596 | J.7609 | 5.408 | 5.412 | 158.34 | 158.55 |
Table 1: The deduced magnetic parameters for CoCexFe2-xO4 (0.0≤ x≤0.10) samples obtained from the M-H loops at 100 K
Area (nm) | Mean (nm) | Min (nm) | Max (nm) |
148.556 | 86.527 | 10.288 | 251 |
147.663 | 71.1 | 26.583 | 253.647 |
146.005 | 85.089 | 21.012 | 145 |
145.112 | 79.468 | 16.884 | 121 |
Average = 46.S nm |
Table 2: The size distributions of CeO2 NPs
Spectrum:Spectrum 525-Ce | ||||||
Element Series | ., Net |
mn.C (% .Wt) | 'iorm. C (% .Wt) | Atom. C (% .at) | Error (% .Sigma) (Wt 3) |
|
Cerium | L-series | 4064 | B9.31 | 9.31 | 48.83 | 26.9 |
Oxygen | K-series | 13405 | 10.69 | 10.69 | 51.17 | l.08 |
Tota l: 100.00 100.00 100.0 |
Table 3: The percentage of chemical elements in the synthesized Ceo2.NPs sample
Observed Band Position (cm)-1 | Assignments |
1311 | C-N Stretching vibration |
1647 | C=C Stretching vibration |
3428 | O-H Stretching vibration |
425, 706 | Cerium Oxide |
Table 4: Top ten keywords and frequency
Nanoparticle | Aspergilus % of Zone inhibition | |||
Ceo2 Nanoparticles | Concentration | Control | ||
100 mg | 200 mg | 300 mg | 17 mm | |
12 mm | 13mm | IS mm | ||
Mucor % of Zone inhibition | ||||
Concentration | Control | |||
100 mg | 200 mg | 300 mg | 22 nun | |
14 mm | 18 nun | 20 mm |
Table 5: Anti-Bactria of Cerium Oxide (Ceo2)
Nanoparticle | Aspergilus % of Zone inhibition | |||
Ceo2 Nanoparticles | Concentration | Control | ||
100 mg | 200 mg | 300 mg | 17 mm | |
12 mm | 13mm | IS mm | ||
Mucor % of Zone inhibition | ||||
Concentration | Control | |||
100 mg | 200 mg | 300 mg | 22 nun | |
14 mm | 18 nun | 20 mm | ||
Nanopartide | BACILLUS SP % of Zone inhibition | |||
Ce02 Nanopartides | Concentration | Control | ||
100 mg | 200 mg | 300 mg | 19 mm | |
14 mm | 15 mm | 17 mm | ||
E. COLI % of Zone inhibition | ||||
Concentration | Control | |||
100 mg | 200 mg | 300 mg | 24 mm | |
16 mm | 20111m | 22 mg |
Table 6: Anti-Bactria of Cerium Oxide (Ceo2)
Sample Particulars | ||||
Description | Conc. (μg) |
Cytotoxicity(%) | Cell viability(%) | Cell viability(%) |
Cl | 5 | 86 | 14 | Severe |
10 | 83 | 17 | Severe | |
50 | 76 | 24 | Severe | |
75 | 77 | 23 | Severe | |
100 | 80 | 20 | Severe |
Table 7: Anti-Bactria of Cerium Oxide (Ceo2.)
Figure 1: The PXRD pattern of Ceo2 Nanoparticles
Figure 2: TEM images of Cerium Oxide (Ceo2) Nanoparticles
Figure 3: The EDX pattern of Ceo2 Nanoparticles
Figure 4: FTIR spectrum of Cerium Oxide (Ceo2)
Figure 5a: UV-Vis absorbance spectra of Ceo2 NPs
Figure 5b: UV-Vis transmittance spectra of Ceo2 NPs
Figure 5c: Photon energy vs.(ahv)2spectrum of Ceo2 NPs
Figure 6: PL spectra of Ceo NPs
Figure 7: Anti-Fungal activity of Cerium Oxide (CeO)
Figure 8: Anti-Bactria of Cerium Oxide (Ceo)
Figure 9: Anti-Bactria of Cerium Oxide (CeO2).
Figure 10: Anti-Bactria of Cerium Oxide (CeO2)
Figure 11: Anti-Bactria of Cerium Oxide (CeO2)
Tables at a glance
Figures at a glance